Managing health care
The recent revelation that data, previously used to support the use of bone marrow transplantation, had been falsified brings into question the legitimate role of this technology. This article suggests ways in which the purchasers can improve overall quality of care by holding transplant programs ac...
Gespeichert in:
Veröffentlicht in: | Compensation & Benefits Management 2000-07, Vol.16 (3), p.46 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 3 |
container_start_page | 46 |
container_title | Compensation & Benefits Management |
container_volume | 16 |
creator | John M Burns, Joanne Miller Miller, Laird |
description | The recent revelation that data, previously used to support the use of bone marrow transplantation, had been falsified brings into question the legitimate role of this technology. This article suggests ways in which the purchasers can improve overall quality of care by holding transplant programs accountable. Some guidelines to be used in the selection of transplant programs are discussed. |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_reports_206602909</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>55587939</sourcerecordid><originalsourceid>FETCH-proquest_reports_2066029093</originalsourceid><addsrcrecordid>eNpjYeA0MDex0DUwM4zgYOAqLs4yMDCwMDUw4mQQ8U3MS0zPzEtXyEhNzCnJUEhOLErlYWBNS8wpTuWF0twMim6uIc4eugVF-YWlqcUl8UWpBflFJcXxRgZmZgZGlgaWxsSoAQCmPya3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>206602909</pqid></control><display><type>article</type><title>Managing health care</title><source>EBSCOhost Business Source Complete</source><creator>John M Burns, Joanne Miller ; Miller, Laird</creator><creatorcontrib>John M Burns, Joanne Miller ; Miller, Laird</creatorcontrib><description>The recent revelation that data, previously used to support the use of bone marrow transplantation, had been falsified brings into question the legitimate role of this technology. This article suggests ways in which the purchasers can improve overall quality of care by holding transplant programs accountable. Some guidelines to be used in the selection of transplant programs are discussed.</description><identifier>ISSN: 0748-061X</identifier><language>eng</language><publisher>New York: Aspen Publishers, Inc</publisher><subject>Accountability ; Beneficiaries ; Bone marrow ; Breast cancer ; Cancer therapies ; Chemotherapy ; Clinical trials ; Employee benefits ; Guidelines ; Health care ; Laboratories ; Metastasis ; Monetary incentives ; Mortality ; Patients ; Physicians ; Prices ; Quality of life ; Reimbursement ; Stem cell transplantation ; Toxicity ; Transplants & implants</subject><ispartof>Compensation & Benefits Management, 2000-07, Vol.16 (3), p.46</ispartof><rights>Copyright Aspen Publishers, Inc. Summer 2000</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>312,780,784,791</link.rule.ids></links><search><creatorcontrib>John M Burns, Joanne Miller</creatorcontrib><creatorcontrib>Miller, Laird</creatorcontrib><title>Managing health care</title><title>Compensation & Benefits Management</title><description>The recent revelation that data, previously used to support the use of bone marrow transplantation, had been falsified brings into question the legitimate role of this technology. This article suggests ways in which the purchasers can improve overall quality of care by holding transplant programs accountable. Some guidelines to be used in the selection of transplant programs are discussed.</description><subject>Accountability</subject><subject>Beneficiaries</subject><subject>Bone marrow</subject><subject>Breast cancer</subject><subject>Cancer therapies</subject><subject>Chemotherapy</subject><subject>Clinical trials</subject><subject>Employee benefits</subject><subject>Guidelines</subject><subject>Health care</subject><subject>Laboratories</subject><subject>Metastasis</subject><subject>Monetary incentives</subject><subject>Mortality</subject><subject>Patients</subject><subject>Physicians</subject><subject>Prices</subject><subject>Quality of life</subject><subject>Reimbursement</subject><subject>Stem cell transplantation</subject><subject>Toxicity</subject><subject>Transplants & implants</subject><issn>0748-061X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpjYeA0MDex0DUwM4zgYOAqLs4yMDCwMDUw4mQQ8U3MS0zPzEtXyEhNzCnJUEhOLErlYWBNS8wpTuWF0twMim6uIc4eugVF-YWlqcUl8UWpBflFJcXxRgZmZgZGlgaWxsSoAQCmPya3</recordid><startdate>20000701</startdate><enddate>20000701</enddate><creator>John M Burns, Joanne Miller</creator><creator>Miller, Laird</creator><general>Aspen Publishers, Inc</general><scope>7WY</scope><scope>7WZ</scope><scope>7XB</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>F~G</scope><scope>K6~</scope><scope>M0C</scope><scope>PQBIZ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PYYUZ</scope><scope>Q9U</scope></search><sort><creationdate>20000701</creationdate><title>Managing health care</title><author>John M Burns, Joanne Miller ; Miller, Laird</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_reports_2066029093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Accountability</topic><topic>Beneficiaries</topic><topic>Bone marrow</topic><topic>Breast cancer</topic><topic>Cancer therapies</topic><topic>Chemotherapy</topic><topic>Clinical trials</topic><topic>Employee benefits</topic><topic>Guidelines</topic><topic>Health care</topic><topic>Laboratories</topic><topic>Metastasis</topic><topic>Monetary incentives</topic><topic>Mortality</topic><topic>Patients</topic><topic>Physicians</topic><topic>Prices</topic><topic>Quality of life</topic><topic>Reimbursement</topic><topic>Stem cell transplantation</topic><topic>Toxicity</topic><topic>Transplants & implants</topic><toplevel>online_resources</toplevel><creatorcontrib>John M Burns, Joanne Miller</creatorcontrib><creatorcontrib>Miller, Laird</creatorcontrib><collection>Access via ABI/INFORM (ProQuest)</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>ProQuest Business Collection</collection><collection>ABI/INFORM Global</collection><collection>ProQuest One Business</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ABI/INFORM Collection China</collection><collection>ProQuest Central Basic</collection><jtitle>Compensation & Benefits Management</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>John M Burns, Joanne Miller</au><au>Miller, Laird</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Managing health care</atitle><jtitle>Compensation & Benefits Management</jtitle><date>2000-07-01</date><risdate>2000</risdate><volume>16</volume><issue>3</issue><spage>46</spage><pages>46-</pages><issn>0748-061X</issn><abstract>The recent revelation that data, previously used to support the use of bone marrow transplantation, had been falsified brings into question the legitimate role of this technology. This article suggests ways in which the purchasers can improve overall quality of care by holding transplant programs accountable. Some guidelines to be used in the selection of transplant programs are discussed.</abstract><cop>New York</cop><pub>Aspen Publishers, Inc</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0748-061X |
ispartof | Compensation & Benefits Management, 2000-07, Vol.16 (3), p.46 |
issn | 0748-061X |
language | eng |
recordid | cdi_proquest_reports_206602909 |
source | EBSCOhost Business Source Complete |
subjects | Accountability Beneficiaries Bone marrow Breast cancer Cancer therapies Chemotherapy Clinical trials Employee benefits Guidelines Health care Laboratories Metastasis Monetary incentives Mortality Patients Physicians Prices Quality of life Reimbursement Stem cell transplantation Toxicity Transplants & implants |
title | Managing health care |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T09%3A01%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Managing%20health%20care&rft.jtitle=Compensation%20&%20Benefits%20Management&rft.au=John%20M%20Burns,%20Joanne%20Miller&rft.date=2000-07-01&rft.volume=16&rft.issue=3&rft.spage=46&rft.pages=46-&rft.issn=0748-061X&rft_id=info:doi/&rft_dat=%3Cproquest%3E55587939%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=206602909&rft_id=info:pmid/&rfr_iscdi=true |